22.08.2017
- Monsanto has signed a global licensing agreement with South Korean biotech ToolGen, gaining access to its CRISPR gene-editing technology. Financial terms were not disclosed. "This...
20.03.2017
- Allergan has secured exclusive access to Editas Medicine’s genome-editing ocular programs under a strategic research and development agreement. The deal covers early stage, first...
22.08.2016
- Casebia Therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has hired new laboratory and office space in Cambridge, Massachusetts, USA, for its primary research...
06.04.2016
- With its expanded consumer healthcare portfolio in mind following the $14 billion acquisition of the relevant Merck & Co business in 2004, Bayer is striving to lift its profile in...
13.10.2015
- Delaware-based US chemical giant DuPont and Caribou Biosciences of California, a leading developer of CRISPR-Cas technologies for genome editing, have signed an agreement to cross...
